Coronavirus Report – Part 91: GSK Japan President Paul Lirette Discusses Strategy and Moves in Pandemic Times Jun. 23, 2020
Coronavirus Report – Part 67: Pandemic Causes 75% Drop in Clinical Trials for Early April May. 7, 2020
Coronavirus Report – Part 27: Pandemic Sees Clinical Trials for New Drugs Suspended, Postponed Apr. 3, 2020
Coronavirus Report – Part 24: Survey Reveals 12 Japanese Pharmaceutical Firms Working to Develop Cures Mar. 24, 2020
Coronavirus Report – Part 15: Kanto Chemical Supplies Japan With Coronavirus Test Kits From South Korean Company Mar. 12, 2020
PeptiDream, Nihon Medi-Physics Plan Joint R&D for Simultaneous Diagnosis and Treatment of Cancer Dec. 21, 2018
Medical & Biological Laboratories to Commercially Launch Development Services in Companion Diagnostics Dec. 10, 2018
